The Rogosin Institute
New York, 10021, United States
Location status: Recruiting
NCT Number: NCT00792155
Autosomal dominant polycystic kidney disease (PKD) is the most common inherited kidney disease, affecting more than 400,000 people in the U.S. and 5 million people worldwide. PKD is the 4th most common cause of kidney failure requiring dialysis and/or transplantation. Over half of all PKD patients develop kidney failure by age 60 years, although age of onset of kidney disease varies widely, even among members of the same family.
Despite the fact this is a relatively common problem, relatively few patients have been studied for a sufficient period of time to fully understand how patients are affected over the course of their lifetime. The reason for creating this repository is to collect information about PKD so that the investigators may fully understand its complications, including high blood pressure, heart attack, and stroke. This information may also aid in the development of improved treatment strategies.
Interested in participating?
Request Info18 year and older
All sexes
Observational
New York, 10021, United States
Location status: Recruiting
Visit #1:
Follow-up Study Visits:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 years
Polycystic kidney disease data repository
Contact information is provided by the study sponsor or research team.
The Rogosin Institute
Other
Autosomal Dominant Polycystic Kidney Disease Data Repository
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06325644
Abnormalities, Multiple, Ciliopathies
Columbus, Ohio, United States
View Trial DetailsNCT02936791
Abnormalities, Multiple, Ciliopathies
Chicago, Illinois, United States
View Trial DetailsNCT01873235
Abnormalities, Multiple, Ciliopathies
Baltimore, Maryland, United States
View Trial DetailsNCT06728228
Abnormalities, Multiple, Anhydramnios
Dallas, Texas, United States
View Trial Details